← Back to headlines
Elite Pharmaceuticals Director Purchases Company Stock
Barry Dash, a director at Elite Pharmaceuticals, purchased $8,610 worth of common stock, signaling insider confidence in the company.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Elon Musk Condemns New Documentary as 'Hit Piece' and Threatens Legal Action
45m ago
UAE Announces $46 Billion Investment Plan to Strengthen Economic Ties with Germany
47m ago
TTM Technologies Prices $500 Million Senior Notes
1h ago
Adobe Beats Q3 Revenue Estimates Despite Wall Street Demand for More AI Growth
1h ago